New Late-Breaking XARELTO ® (rivaroxaban) and INVOKANA® (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news